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Although the cytokine profile in nasal polyposis is well 
documented, little is known about cytokines associated to 
cystic fibrosis. Aim: Assess the expression of cytokines IL¬4, 
IL¬5, IL¬6, IL¬8, GM¬-CSF and IFN¬-y, analyzed through RT-
PCR, in the polyps of patients with cystic fibrosis. Materials 
and Methods: A cross-sectional, prospective study was 
carried out with 24 patients, 13 of whom had cystic fibrosis 
and nasal polyposis (Cystic Fibrosis Group) and 11 had 
normal otorhinolaryngological exams (Control Group). The 
average age was 21 years (3¬57); 12 participants were males 
and 12 were females. The cytokine profile was studied in 
mucosal fragments (Control Group) or nasal polyps (Cystic 
Fibrosis Group) through RT¬PCR. Transcriptions were studied 
for cytokines IL¬4, IL¬5, IL¬6, IL¬8, IFN¬y and GM¬CSF, 
adjusted for the ß¬-actin value. Results: Interleukins 5, 6, 
8 and GM¬CSF were similar in both groups (p>0.05). There 
were lower values of IFN-y¬ (p=0.03) and a strong tendency 
toward an increase in IL¬4 (p=0.06) in the Cystic Fibrosis 
Group. Conclusion: Inflammatory and structural cells may 
produce messenger RNA for IL¬4, blocking the production of 
other cytokines such as IFN-y, suggesting the participation of 
this mechanism in the formation of polyps in cystic fibrosis.
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INTRODUCTION
Nasal polyposis (NP) is a chronic inflammatory 
disease that involves the nasal mucosa. It is characterized 
by the presence of multiple grayish nasal polyps located 
bilaterally and originating from the middle meatus1,2. 
NP involves 0.5% of the population; eosinophilic nasal 
polyposis (ENP) accounts for 85% of the cases, while 
non-eosinophilic nasal polyposis (NENP) accounts for the 
remaining 15%1,2.
Diseases with concurrent NENP include mucovisci-
dosis or cystic fibrosis (CF). This is a congenital autosomal 
recessive disease found in 1 of every 2,500 individuals. 
Patients experience exocrine gland dysfunction, chronic 
pulmonary obstruction, and pancreas failure. Polyps are 
present in 20% of the patients3,4.
Various pathogenic mechanisms have been propo-
sed to explain its development, among which are allergy 
and inflammation. Although the genesis of allergic rhinitis 
is IgE-specific, its prevalence is of only 1.5% of the patients 
with polyposis, and similar levels of immunoglobulin E 
were observed in polyps of both allergic and non-allergic 
patients5.
The inflammatory micro-environment, cytokines, 
adhesion molecules, and ion transportation have been re-
cently studied to clarify the pathogenesis of nasal polyps6.
More specifically, eosinophils and mediators such as 
interleukins 4 (IL-4), 5 (IL-5), 6 (IL-6), 8 (IL-8), granulocyte-
macrophage colony-stimulating factors (GM-CSF) and 
interferon gamma (IFN-γ), were given special attention 
after elevated values were observed in patients with ENP1.
Unfortunately, few papers have looked into NP and 
the role of cytokines in CF.
Therefore, this study aims to analyze the expression 
of messenger ribonucleic acid (mRNA) for IL-4, IL-5, IL-6, 
IL-8, GM-CSF, and INF-γ in patients with cystic fibrosis and 
control subjects through reverse transcription polymerase 
chain reaction (RT-PCR).
MATERIALS AND METHOD
This is a cross-sectional study done on 13 patients 
with NP and 124 patients with CF. Six (46.15%) of the 13 
patients were males and seven (53.85%) were females with 
mean age of 22.45 years (6-57).
The following criteria was used to enroll and ex-
clude subjects from the study.
Enrollment criteria
Diagnosis of CF based on two dosages of elec-
trolytes in sweat with sodium and chlorine levels above 
60mEq/l.
Patients with CF and NP.
Exclusion criteria
Upper or lower airway infection, use of topical or 
systemic glucocorticoids or antihistamines within 30 days 
of the study.
The control group was made up of 13 individuals 
who looked for our service to undergo ENT surgery. Nasal 
examination did not show any alterations for these sub-
jects, and allergies were ruled out after dermal puncture 
tests7; none of them was taking topical/systemic gluco-
corticoids or antihistamines. Two patients were excluded 
due to immediate postoperative acute sinusitis. From the 
remaining eleven, five (45.45%) were females, six (54.54%) 
were males, with a mean age of 17.7 years (3-43).
The study was carried out from December, 2003 
through December of 2004, and was approved by the 
Ethics in Research Committee of the University of Minas 
Gerais Medical School Hospital, under protocol # nº. 
209/03. All the patients signed the post-informed consent 
form to participate in this study.
The cytokine profile was analyzed looking at mu-
cosa fragments from the middle turbinate (control group) 
and polyp specimens (cystic fibrosis group) to collect 
mRNA for further analysis using RT-PCR.
Polyp fragments from the CF group were collected 
at the ENT outpatient ward using an EXPLORENT® forceps 
(Karl Storz, Miami, Florida, USA) and a Storz 30º, 4.0 mm 
endoscope (Karl Storz, Miami, FL, USA).
Normal nasal mucosa fragments from control group 
patients were collected in the middle turbinate using an 
EXPLORENT® forceps (Karl Storz, Miami, FL, USA) and 
a Storz 30º, 4.0 mm endoscope (Karl Storz, Miami, FL, 
USA) during ENT surgical procedures. Patients were under 
general anesthesia and the collected specimens were sent 
for further testing using RT-PCR.
Transcriptions for cytokines IL-4, IL-5, IL-6, IL-8, 
GM-CSF, and INF-γ were analyzed and adjusted by the 
β-actin coefficient8. After cooling the samples to -80°, 
RNA extraction was done using reagent Trizol® (Invitron 
Corporation, Carlsbad, California, USA) in accordance with 
the manufacturer’s recommendations. RNA concentration 
in the samples was quantified in a spectrophotometer for 
the wavelength of 260 nm and integrity was assessed throu-
gh denaturating gel electrophoresis using 0.8% agarose8. 
Deoxyribonucleic acid (DNA) was synthesized from 1.25μg 
of total RNA using random hexamer initiators (Promega 
Corporation, Madison, WI, USA) and reverse transcriptase 
system SuperScript II (Invitron Corporation, Carlsbad, CA, 
USA) as recommended by the manufacturers. PCR products 
were analyzed through silver-stained 8% polyacrylamide 
gel electrophoresis. The gels were photographed and 
results analyzed through densitometry using device Alpha-
Digidoc 1201 TM (AlphaInotech, San Leandro, CA, USA). 
The resulting PCR bands for each sample were analyzed 
through densitometry using program AlphaEaseFC release 
3.3.0 (AlphaInotech, San Leandro, CA, USA).
ANOVA (analysis of variance) parametric tests and 
Student’s T-test were used in the statistical analysis to com-
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pare two mean values and 5% was adopted as statistical 
significance level.
RESULTS
Table 1 shows that no statistically significant diffe-
rences were found when IL-5, IL-6, IL-8 and GM-CSF values 
were compared between groups (p>0.05).
Table 1 also shows higher values for IL-4 (p=0.06) 
strongly tending to statistical significance and low values 
for INF-γ (p=0.03) in the cystic fibrosis group when com-
pared to the control group.
DISCUSSION
Cytokines are secreted by inflammatory cells (lym-
phocytes, eosinophils, and neutrophils) and constituting 
cells (mastocytes, fibroblasts, epithelial cells, and macro-
phages)9. They regulate biologic processes such as gro-
wth, cell activation, chemotaxis, inflammation, immunity, 
tissue repair, fibrosis, and morphogenesis10. The profile 
of cytokines and inflammatory cells in ENP is well docu-
mented in the literature; conversely, very little is known 
on the pathogenesis of NP and cytokines in CF patients.
Interleukin 8 is the main cytokine related to NP 
in CF patients. Various authors have observed increased 
levels of IL-8 and neutrophils when comparing such pa-
tients to subjects with ENP11. The main sources of IL-8 
are neutrophils and their byproducts such as elastase, 
oxidants, and IL-812,13.
Sobol et al.12 looked at individuals with chronic si-
nusitis and CF and compared them to healthy subjects and 
showed that nasal disease in CF consists of a neutrophilic 
infiltrate with increased levels of IL-8, similarly to what is 
found in patients with lung disorders12.
It is worth mentioning that, similarly to what was 
found in this study, Noah et al.14 and Black et al.15 showed 
that increased IL-8 levels are consequent acute associated 
bacterial infection. In the absence of infection - infection 
being one of the exclusion criterion in this study - both 
nasal and lung secretions showed normal IL-8 levels14,15.
The respiratory epithelium impacts polyp inflamma-
tory mediation, mainly in ENP, through the production of 
cytokines such as IL-6 and GM-CSF16,17. Thus, differently 
from Bernstein et al.6 and Mulloi et al.16 in which large 
epithelial lesions and consequent increases in GM-CSF and 
IL-6 were respectively shown, for nasal polyps this study 
showed a wide range of normal values for such cytoki-
nes, suggesting greater epithelium integrity on NP in CF 
patients and a lesser participation of IL-6 and GM-CSF in 
this micro inflammatory environment.
Eosinophils had genetic expression for IL-5 in pa-
tients with ENP10,18,19.
According to Jankowski et al.20, eosinophils, even at 
lower levels as found in NP CF subjects, play an important 
role in inflammation in the development of polyps20.
As indicated on Table 1, no increases were seen on 
IL-5 as similarly found by Clayes et al.4 and Sobol et al.12. 
These results suggest that if eosinophils have an important 
role in NP associated with CF, different mechanisms exist 
for eosinophilia and are independent from IL-5.
Interestingly enough, as seen on Table 1, we found 
that increased levels of IL-4 tended towards statistical signi-
ficance and low levels of INF-γ in the cystic fibrosis group.
Table 1. Comparison between age and cytokine level adjusted for β-actin.
l Group Cystic Fibrosis Group
Variable Mean SD Median Amplitude Mean SD Median Amplitude p-value
IL-4 38538,0 21015,0 36495,9
12558,3-
82459,7
64287,5 32835,1 56187,1
20064,7-
104356,6
0,06
IL-5 27803,6 15974,8 23625,3
6444,0-
57867,5
29918,5 22119,2 28308,6
4328,7-
81327,9
0,88
IL-6 60259,9 52404,5 40113,7
15571,0-
175675,4
60631,7 34630,0 67502,5
6905,3-
112570,8
0,51
IL-8 66254,5 47421,5 53019,9
13326,8-
171973,0
74032,6 27356,4 78545,1
24567,5-
120438,6
0,40
IFN-γ 153510,3 65026,5 126851,7
80603,1-
281112,5
100839,3 40426,2 94889,7
48449,2-
190901,9
0,03
GM-CSF 4958,1 1306,4 5286,0
1602,2-
6455,9
4119,6 2627,1 3033,9
918,1-
8446,1
0,40
Age 17,7 13,6 15,0 3-43 21,1 12,5 20,0 6-57 0,32
β-actina 130960 22315 154549
90090-
174528
150324 23318 135790
103700-
179450
0,052
SD=standard deviation.
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Similarly as found in our study, Clayes et al.4 and 
Dellacono et al.21 showed lower levels of INF-γ in patients 
with CF and nasal polyposis when compared to subjects 
with eosinophilic polyps. INF-γ was increased in CF pa-
tients only in acute sinusitis events12.
In contrast, we could not find papers in the lite-
rature showing altered IL-4 values in patients with nasal 
polyposis and cystic fibrosis.
Bacterial lipopolysaccharides (LPS) bind to the 
receptor of CD4+ T-cells (T-helper 2 cells) and stimulate 
the production of IL-4, leading to increased IgE values22-24. 
By its turn, INF-γ introduces an opposite effect through 
stimulation of T-helper 1 cells (Th1) and by blocking the 
production of IgE and T-helper 2 cells (Th2), principally 
IL-4 and IL-524.
Originally defined as an antiviral agent, INF-γ plays 
an important role in stimulating bactericide action by 
macrophages, antigen presentation through MHC (major 
histocompatibility complex) molecules, and leukocyte-en-
dothelium interaction25,26. It suppression leads to bacterial 
proliferation due to the absence of intracellular clearance 
or by epithelial ionic alterations25,26.
Thus, reductions on INF-γ levels as observed in this 
study would explain the presence of bacteria or bacterial 
LPS in the intracellular realm. These bacteria would sti-
mulate the production of IL-4 by Th2 cells. The outcome 
would be intense inflammation with increased levels of 
eosinophilic cationic protein (ECP), total IgE, led by incre-
ased levels of IL-4 and reduced levels of INF-γ23,24.
Therefore, Staphylococcus aureus, Pseudomonas 
aeruginosa or bacterial LPS could induce eosinophilic in-
flammation and the synthesis of polyclonal IgE, elevating 
total IgE levels led by increased IL-4 levels and reduced 
levels of INF-γ23,24. Enteroxin would thus modify nasal 
polyposis through the IgE released by mastocytes and 
would act as an alternative mechanism to allergy24.
CONCLUSION
The expression of mRNA for interleukins 5, 6, 8, 
and GM-CSF analyzed through RT-PCR was similar among 
the control and cystic fibrosis groups. Low INF-γ levels 
and tendency to increased IL-4 levels were found in the 
group with cystic fibrosis.
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